James M. Frincke
Keine laufenden Positionen mehr
Profil
James M.
Frincke served as Vice President of Research & Development at Eli Lilly & Co., Hybritech, Inc., and Systemix, Inc. He was also President, CEO & Director at Harbor Diversified, Inc. and Chief Technical Officer at Premier Biomedical, Inc. Additionally, he served as VP of Therapeutics Research & Development at Prolinx, Inc. Frincke received his undergraduate and doctorate degrees from the University of California, Davis.
Ehemalige bekannte Positionen von James M. Frincke
| Unternehmen | Position | Ende |
|---|---|---|
| Prolinx, Inc. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1997 |
Systemix, Inc.
 Systemix, Inc. Medical/Nursing ServicesHealth Services Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million. | Technik-/Wissenschafts-/F&E-Leiter | 01.06.1995 |
Hybritech, Inc.
 Hybritech, Inc. Miscellaneous Commercial ServicesCommercial Services Hybritech, Inc. provides prostate diagnostic testing services. The company is headquartered in San Diego, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.02.1991 |
| ELI LILLY AND COMPANY | Technik-/Wissenschafts-/F&E-Leiter | 01.02.1991 |
| PREMIER BIOMEDICAL, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von James M. Frincke
| University of California, Davis | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| HARBOR DIVERSIFIED, INC. | Health Technology |
| PREMIER BIOMEDICAL, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Systemix, Inc.
Systemix, Inc. Medical/Nursing ServicesHealth Services Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million. | Health Services |
Hybritech, Inc.
Hybritech, Inc. Miscellaneous Commercial ServicesCommercial Services Hybritech, Inc. provides prostate diagnostic testing services. The company is headquartered in San Diego, CA. | Commercial Services |
| Prolinx, Inc. |
